GanedenBC30

Bacillus coagulans GBI-30, 6086 · Ganeden, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GanedenBC30, covering 2013-08-09 to 2019-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System [Phase 2]